Effect of Bone Marrow Stromal Cells Derived miR-26b on Chondrocytes of Osteoporosis Rats

Haipeng Chen ¹, Yingjie Shi ¹, Yibo Zhu ¹

⁰Department of Orthopedics, The Third Clinical Medical School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Annals of Clinical and Laboratory Science +

|

September 18, 2024

View abstract on PubMed

Summary

MicroRNA-26b (miR-26b) promotes osteoporosis by targeting sirtuin 2 (SIRT2) in bone cells. This finding in an osteoporosis rat model suggests miR-26b as a potential therapeutic target for bone disease.

Area Of Science

Biochemistry
Molecular Biology
Cell Biology

Background

Osteoporosis is a prevalent bone disease.
MicroRNA-26b (miR-26b) is implicated in osteogenesis and osteoporosis.
The direct role of miR-26b in bone formation requires further elucidation.

Purpose Of The Study

To investigate the direct involvement of miR-26b in osteoporosis.
To determine the regulatory mechanism of miR-26b in bone marrow stromal cells (BMSCs).
To explore the therapeutic potential of targeting miR-26b for osteoporosis.

Main Methods

Oophorectomized rat model of osteoporosis.
Detection of miR-26b and exosome markers (CD63, CD81) using RT-PCR and electron microscopy.
Bioinformatics and luciferase assays to identify miR-26b targets.
Assessment of chondrocyte proliferation and apoptosis.

Main Results

miR-26b is elevated in BMSCs and promotes chondrocyte proliferation.
miR-26b directly targets sirtuin 2 (SIRT2).
Silencing SIRT2 reversed the effects of elevated miR-26b on chondrocytes, confirming the target interaction.

Conclusions

miR-26b is highly expressed in osteoporosis.
miR-26b targets SIRT2 to promote proliferation and inhibit apoptosis of osteoporotic chondrocytes.
miR-26b represents a potential therapeutic target for osteoporosis treatment.

Keywords:

mir-26b osteoporosis sirt2